Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

52
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
52
Standards of Care II01:19

Standards of Care II

1.1K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.1K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

546
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
546
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

10.4K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.4K
Healthcare Agencies II01:17

Healthcare Agencies II

1.1K
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
1.1K
Standards of Care I01:22

Standards of Care I

1.2K
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SIGS in another language.

American pharmacy·1982
Same author

Parasitic diseases: on the rise, but new drugs coming.

American pharmacy·1981
Same author

An interview with FDA commissioner Hayes.

American pharmacy·1981
Same author

APhA's drug abuse policies.

American pharmacy·1980
Same author

DEA's changing requirements.

American pharmacy·1980
Same author

On the rise: sexually transmitted diseases.

American pharmacy·1980

Related Experiment Video

Updated: Feb 26, 2026

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
10:17

A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

Published on: April 29, 2022

2.9K

Mandatory PPIs to begin in 1981; APhA issues strong objections

W E Small

    American Pharmacy
    |November 1, 1980
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials
    08:55

    Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials

    Published on: June 25, 2018

    8.6K
    Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
    08:38

    Habituation and Prepulse Inhibition of Acoustic Startle in Rodents

    Published on: September 1, 2011

    75.9K

    Related Experiment Videos

    Last Updated: Feb 26, 2026

    A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors
    10:17

    A Mass Spectrometry-Based Approach to Identify Phosphoprotein Phosphatases and their Interactors

    Published on: April 29, 2022

    2.9K
    Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials
    08:55

    Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials

    Published on: June 25, 2018

    8.6K
    Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
    08:38

    Habituation and Prepulse Inhibition of Acoustic Startle in Rodents

    Published on: September 1, 2011

    75.9K